{
  "ticker": "REGN",
  "year": 2022,
  "quarter": 4,
  "last_updated": "2025-04-15T16:12:15.965878",
  "count": 180,
  "transactions": [
    {
      "id": 40260,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "COLES N ANTHONY",
      "reporting_owner_cik": "0001197018",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-28",
      "transaction_shares": "2145",
      "transaction_price": "374.12",
      "transaction_type": "M",
      "shares_after_transaction": "3238"
    },
    {
      "id": 72324,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "COLES N ANTHONY",
      "reporting_owner_cik": "0001197018",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-28",
      "transaction_shares": "2145",
      "transaction_price": "374.12",
      "transaction_type": "M",
      "shares_after_transaction": "3238"
    },
    {
      "id": 113238,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "COLES N ANTHONY",
      "reporting_owner_cik": "0001197018",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-28",
      "transaction_shares": "2145",
      "transaction_price": "374.12",
      "transaction_type": "M",
      "shares_after_transaction": "3238"
    },
    {
      "id": 160249,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "COLES N ANTHONY",
      "reporting_owner_cik": "0001197018",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-28",
      "transaction_shares": "2145",
      "transaction_price": "374.12",
      "transaction_type": "M",
      "shares_after_transaction": "3238"
    },
    {
      "id": 214451,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "COLES N ANTHONY",
      "reporting_owner_cik": "0001197018",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-28",
      "transaction_shares": "2145",
      "transaction_price": "374.12",
      "transaction_type": "M",
      "shares_after_transaction": "3238"
    },
    {
      "id": 40208,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "VAGELOS P ROY",
      "reporting_owner_cik": "0001013064",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-20",
      "transaction_shares": "30",
      "transaction_price": "728.86",
      "transaction_type": "I",
      "shares_after_transaction": "2072"
    },
    {
      "id": 72256,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "VAGELOS P ROY",
      "reporting_owner_cik": "0001013064",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-20",
      "transaction_shares": "30",
      "transaction_price": "728.86",
      "transaction_type": "I",
      "shares_after_transaction": "2072"
    },
    {
      "id": 113164,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "VAGELOS P ROY",
      "reporting_owner_cik": "0001013064",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-20",
      "transaction_shares": "30",
      "transaction_price": "728.86",
      "transaction_type": "I",
      "shares_after_transaction": "2072"
    },
    {
      "id": 160164,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "VAGELOS P ROY",
      "reporting_owner_cik": "0001013064",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-20",
      "transaction_shares": "30",
      "transaction_price": "728.86",
      "transaction_type": "I",
      "shares_after_transaction": "2072"
    },
    {
      "id": 214334,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "VAGELOS P ROY",
      "reporting_owner_cik": "0001013064",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-20",
      "transaction_shares": "30",
      "transaction_price": "728.86",
      "transaction_type": "I",
      "shares_after_transaction": "2072"
    },
    {
      "id": 40217,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-12-16",
      "transaction_shares": "3798",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "33884"
    },
    {
      "id": 40221,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-12-16",
      "transaction_shares": "3853",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "32844"
    },
    {
      "id": 40226,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-12-16",
      "transaction_shares": "4129",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "60747"
    },
    {
      "id": 40247,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2022-12-16",
      "transaction_shares": "2752",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "23110"
    },
    {
      "id": 40249,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2022-12-16",
      "transaction_shares": "1926",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "18581"
    },
    {
      "id": 40258,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2022-12-16",
      "transaction_shares": "1101",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "53100"
    },
    {
      "id": 40265,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "VAGELOS P ROY",
      "reporting_owner_cik": "0001013064",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-16",
      "transaction_shares": "1651",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "324083"
    },
    {
      "id": 40266,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-12-16",
      "transaction_shares": "2973",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "22079"
    },
    {
      "id": 72266,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-12-16",
      "transaction_shares": "3798",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "33884"
    },
    {
      "id": 72272,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-12-16",
      "transaction_shares": "3853",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "32844"
    },
    {
      "id": 72278,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-12-16",
      "transaction_shares": "4129",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "60747"
    },
    {
      "id": 72308,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2022-12-16",
      "transaction_shares": "2752",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "23110"
    },
    {
      "id": 72310,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2022-12-16",
      "transaction_shares": "1926",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "18581"
    },
    {
      "id": 72322,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2022-12-16",
      "transaction_shares": "1101",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "53100"
    },
    {
      "id": 72333,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "VAGELOS P ROY",
      "reporting_owner_cik": "0001013064",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-16",
      "transaction_shares": "1651",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "324083"
    },
    {
      "id": 72334,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-12-16",
      "transaction_shares": "2973",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "22079"
    },
    {
      "id": 113175,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-12-16",
      "transaction_shares": "3798",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "33884"
    },
    {
      "id": 113182,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-12-16",
      "transaction_shares": "3853",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "32844"
    },
    {
      "id": 113188,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-12-16",
      "transaction_shares": "4129",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "60747"
    },
    {
      "id": 113219,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2022-12-16",
      "transaction_shares": "2752",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "23110"
    },
    {
      "id": 113221,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2022-12-16",
      "transaction_shares": "1926",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "18581"
    },
    {
      "id": 113236,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2022-12-16",
      "transaction_shares": "1101",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "53100"
    },
    {
      "id": 113248,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "VAGELOS P ROY",
      "reporting_owner_cik": "0001013064",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-16",
      "transaction_shares": "1651",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "324083"
    },
    {
      "id": 113249,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-12-16",
      "transaction_shares": "2973",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "22079"
    },
    {
      "id": 160176,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-12-16",
      "transaction_shares": "3798",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "33884"
    },
    {
      "id": 160183,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-12-16",
      "transaction_shares": "3853",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "32844"
    },
    {
      "id": 160189,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-12-16",
      "transaction_shares": "4129",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "60747"
    },
    {
      "id": 160226,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2022-12-16",
      "transaction_shares": "2752",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "23110"
    },
    {
      "id": 160228,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2022-12-16",
      "transaction_shares": "1926",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "18581"
    },
    {
      "id": 160246,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2022-12-16",
      "transaction_shares": "1101",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "53100"
    },
    {
      "id": 160260,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "VAGELOS P ROY",
      "reporting_owner_cik": "0001013064",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-16",
      "transaction_shares": "1651",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "324083"
    },
    {
      "id": 160261,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-12-16",
      "transaction_shares": "2973",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "22079"
    },
    {
      "id": 214352,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-12-16",
      "transaction_shares": "3798",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "33884"
    },
    {
      "id": 214362,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-12-16",
      "transaction_shares": "3853",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "32844"
    },
    {
      "id": 214369,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-12-16",
      "transaction_shares": "4129",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "60747"
    },
    {
      "id": 214418,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2022-12-16",
      "transaction_shares": "2752",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "23110"
    },
    {
      "id": 214420,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2022-12-16",
      "transaction_shares": "1926",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "18581"
    },
    {
      "id": 214448,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2022-12-16",
      "transaction_shares": "1101",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "53100"
    },
    {
      "id": 214471,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "VAGELOS P ROY",
      "reporting_owner_cik": "0001013064",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-16",
      "transaction_shares": "1651",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "324083"
    },
    {
      "id": 214473,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-12-16",
      "transaction_shares": "2973",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "22079"
    },
    {
      "id": 40213,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-12-09",
      "transaction_shares": "274",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "19370"
    },
    {
      "id": 40219,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-12-09",
      "transaction_shares": "492",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "30086"
    },
    {
      "id": 40225,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2022-12-09",
      "transaction_shares": "247",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "16655"
    },
    {
      "id": 40240,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-12-09",
      "transaction_shares": "492",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "56618"
    },
    {
      "id": 40241,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2022-12-09",
      "transaction_shares": "492",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "20358"
    },
    {
      "id": 72262,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-12-09",
      "transaction_shares": "274",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "19370"
    },
    {
      "id": 72268,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-12-09",
      "transaction_shares": "492",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "30086"
    },
    {
      "id": 72277,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2022-12-09",
      "transaction_shares": "247",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "16655"
    },
    {
      "id": 72300,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-12-09",
      "transaction_shares": "492",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "56618"
    },
    {
      "id": 72302,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2022-12-09",
      "transaction_shares": "492",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "20358"
    },
    {
      "id": 113170,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-12-09",
      "transaction_shares": "274",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "19370"
    },
    {
      "id": 113177,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-12-09",
      "transaction_shares": "492",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "30086"
    },
    {
      "id": 113187,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2022-12-09",
      "transaction_shares": "247",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "16655"
    },
    {
      "id": 113211,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-12-09",
      "transaction_shares": "492",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "56618"
    },
    {
      "id": 113213,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2022-12-09",
      "transaction_shares": "492",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "20358"
    },
    {
      "id": 160171,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-12-09",
      "transaction_shares": "274",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "19370"
    },
    {
      "id": 160178,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-12-09",
      "transaction_shares": "492",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "30086"
    },
    {
      "id": 160188,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2022-12-09",
      "transaction_shares": "247",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "16655"
    },
    {
      "id": 160218,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-12-09",
      "transaction_shares": "492",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "56618"
    },
    {
      "id": 160220,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2022-12-09",
      "transaction_shares": "492",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "20358"
    },
    {
      "id": 214344,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-12-09",
      "transaction_shares": "274",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "19370"
    },
    {
      "id": 214357,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-12-09",
      "transaction_shares": "492",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "30086"
    },
    {
      "id": 214368,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2022-12-09",
      "transaction_shares": "247",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "16655"
    },
    {
      "id": 214407,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-12-09",
      "transaction_shares": "492",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "56618"
    },
    {
      "id": 214411,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2022-12-09",
      "transaction_shares": "492",
      "transaction_price": "753.28",
      "transaction_type": "F",
      "shares_after_transaction": "20358"
    },
    {
      "id": 40235,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-08",
      "transaction_shares": "218",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "1300"
    },
    {
      "id": 40246,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-12-08",
      "transaction_shares": "3000",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "31744"
    },
    {
      "id": 72294,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-08",
      "transaction_shares": "218",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "1300"
    },
    {
      "id": 72307,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-12-08",
      "transaction_shares": "3000",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "31744"
    },
    {
      "id": 113204,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-08",
      "transaction_shares": "218",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "1300"
    },
    {
      "id": 113218,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-12-08",
      "transaction_shares": "3000",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "31744"
    },
    {
      "id": 160209,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-08",
      "transaction_shares": "218",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "1300"
    },
    {
      "id": 160225,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-12-08",
      "transaction_shares": "3000",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "31744"
    },
    {
      "id": 214396,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-08",
      "transaction_shares": "218",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "1300"
    },
    {
      "id": 214417,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-12-08",
      "transaction_shares": "3000",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "31744"
    },
    {
      "id": 40232,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-12-01",
      "transaction_shares": "2500",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "31244"
    },
    {
      "id": 40239,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-01",
      "transaction_shares": "3",
      "transaction_price": "752.57",
      "transaction_type": "S",
      "shares_after_transaction": "19379"
    },
    {
      "id": 40271,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-12-01",
      "transaction_shares": "1100",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 72288,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-12-01",
      "transaction_shares": "2500",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "31244"
    },
    {
      "id": 72298,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-01",
      "transaction_shares": "3",
      "transaction_price": "752.57",
      "transaction_type": "S",
      "shares_after_transaction": "19379"
    },
    {
      "id": 72341,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-12-01",
      "transaction_shares": "1100",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 113198,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-12-01",
      "transaction_shares": "2500",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "31244"
    },
    {
      "id": 113209,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-01",
      "transaction_shares": "3",
      "transaction_price": "752.57",
      "transaction_type": "S",
      "shares_after_transaction": "19379"
    },
    {
      "id": 113256,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-12-01",
      "transaction_shares": "1100",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 160203,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-12-01",
      "transaction_shares": "2500",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "31244"
    },
    {
      "id": 160215,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-01",
      "transaction_shares": "3",
      "transaction_price": "752.57",
      "transaction_type": "S",
      "shares_after_transaction": "19379"
    },
    {
      "id": 160269,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-12-01",
      "transaction_shares": "1100",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 214389,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-12-01",
      "transaction_shares": "2500",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "31244"
    },
    {
      "id": 214404,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-01",
      "transaction_shares": "3",
      "transaction_price": "752.57",
      "transaction_type": "S",
      "shares_after_transaction": "19379"
    },
    {
      "id": 214481,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-12-01",
      "transaction_shares": "1100",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 40273,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-11-22",
      "transaction_shares": "50000",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "80578"
    },
    {
      "id": 72345,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-11-22",
      "transaction_shares": "50000",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "80578"
    },
    {
      "id": 113260,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-11-22",
      "transaction_shares": "50000",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "80578"
    },
    {
      "id": 160274,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-11-22",
      "transaction_shares": "50000",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "80578"
    },
    {
      "id": 214487,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-11-22",
      "transaction_shares": "50000",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "80578"
    },
    {
      "id": 40269,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-11-14",
      "transaction_shares": "1360",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "57110"
    },
    {
      "id": 72337,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-11-14",
      "transaction_shares": "1360",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "57110"
    },
    {
      "id": 113252,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-11-14",
      "transaction_shares": "1360",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "57110"
    },
    {
      "id": 160264,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-11-14",
      "transaction_shares": "1360",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "57110"
    },
    {
      "id": 214476,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-11-14",
      "transaction_shares": "1360",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "57110"
    },
    {
      "id": 40229,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-08",
      "transaction_shares": "2431",
      "transaction_price": "374.12",
      "transaction_type": "M",
      "shares_after_transaction": "3513"
    },
    {
      "id": 40244,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2022-11-08",
      "transaction_shares": "330",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "52465"
    },
    {
      "id": 72284,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-08",
      "transaction_shares": "2431",
      "transaction_price": "374.12",
      "transaction_type": "M",
      "shares_after_transaction": "3513"
    },
    {
      "id": 72305,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2022-11-08",
      "transaction_shares": "330",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "52465"
    },
    {
      "id": 113194,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-08",
      "transaction_shares": "2431",
      "transaction_price": "374.12",
      "transaction_type": "M",
      "shares_after_transaction": "3513"
    },
    {
      "id": 113216,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2022-11-08",
      "transaction_shares": "330",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "52465"
    },
    {
      "id": 160196,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-08",
      "transaction_shares": "2431",
      "transaction_price": "374.12",
      "transaction_type": "M",
      "shares_after_transaction": "3513"
    },
    {
      "id": 160223,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2022-11-08",
      "transaction_shares": "330",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "52465"
    },
    {
      "id": 214381,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-08",
      "transaction_shares": "2431",
      "transaction_price": "374.12",
      "transaction_type": "M",
      "shares_after_transaction": "3513"
    },
    {
      "id": 214414,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2022-11-08",
      "transaction_shares": "330",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "52465"
    },
    {
      "id": 40243,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-11-04",
      "transaction_shares": "1000",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "20644"
    },
    {
      "id": 40259,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-11-04",
      "transaction_shares": "34000",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "64578"
    },
    {
      "id": 72304,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-11-04",
      "transaction_shares": "1000",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "20644"
    },
    {
      "id": 72323,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-11-04",
      "transaction_shares": "34000",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "64578"
    },
    {
      "id": 113215,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-11-04",
      "transaction_shares": "1000",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "20644"
    },
    {
      "id": 113237,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-11-04",
      "transaction_shares": "34000",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "64578"
    },
    {
      "id": 160222,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-11-04",
      "transaction_shares": "1000",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "20644"
    },
    {
      "id": 160248,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-11-04",
      "transaction_shares": "34000",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "64578"
    },
    {
      "id": 214413,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-11-04",
      "transaction_shares": "1000",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "20644"
    },
    {
      "id": 214450,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-11-04",
      "transaction_shares": "34000",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "64578"
    },
    {
      "id": 40252,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-01",
      "transaction_shares": "2",
      "transaction_price": "750.0",
      "transaction_type": "S",
      "shares_after_transaction": "19480"
    },
    {
      "id": 40264,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-11-01",
      "transaction_shares": "1100",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 72313,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-01",
      "transaction_shares": "2",
      "transaction_price": "750.0",
      "transaction_type": "S",
      "shares_after_transaction": "19480"
    },
    {
      "id": 72332,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-11-01",
      "transaction_shares": "1100",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 113226,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-01",
      "transaction_shares": "2",
      "transaction_price": "750.0",
      "transaction_type": "S",
      "shares_after_transaction": "19480"
    },
    {
      "id": 113247,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-11-01",
      "transaction_shares": "1100",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 160236,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-01",
      "transaction_shares": "2",
      "transaction_price": "750.0",
      "transaction_type": "S",
      "shares_after_transaction": "19480"
    },
    {
      "id": 160258,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-11-01",
      "transaction_shares": "1100",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 214431,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-01",
      "transaction_shares": "2",
      "transaction_price": "750.0",
      "transaction_type": "S",
      "shares_after_transaction": "19480"
    },
    {
      "id": 214469,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-11-01",
      "transaction_shares": "1100",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 40267,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-10-31",
      "transaction_shares": "2000",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "30744"
    },
    {
      "id": 72335,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-10-31",
      "transaction_shares": "2000",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "30744"
    },
    {
      "id": 113250,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-10-31",
      "transaction_shares": "2000",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "30744"
    },
    {
      "id": 160262,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-10-31",
      "transaction_shares": "2000",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "30744"
    },
    {
      "id": 214474,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-10-31",
      "transaction_shares": "2000",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "30744"
    },
    {
      "id": 40268,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-10-14",
      "transaction_shares": "1500",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "30244"
    },
    {
      "id": 72336,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-10-14",
      "transaction_shares": "1500",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "30244"
    },
    {
      "id": 113251,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-10-14",
      "transaction_shares": "1500",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "30244"
    },
    {
      "id": 160263,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-10-14",
      "transaction_shares": "1500",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "30244"
    },
    {
      "id": 214475,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2022-10-14",
      "transaction_shares": "1500",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "30244"
    },
    {
      "id": 20273,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2022-10-05",
      "transaction_shares": "1844",
      "transaction_price": "749.0",
      "transaction_type": "S",
      "shares_after_transaction": "16425"
    },
    {
      "id": 40238,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2022-10-05",
      "transaction_shares": "1844",
      "transaction_price": "749.0",
      "transaction_type": "S",
      "shares_after_transaction": "16425"
    },
    {
      "id": 72297,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2022-10-05",
      "transaction_shares": "1844",
      "transaction_price": "749.0",
      "transaction_type": "S",
      "shares_after_transaction": "16425"
    },
    {
      "id": 113207,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2022-10-05",
      "transaction_shares": "1844",
      "transaction_price": "749.0",
      "transaction_type": "S",
      "shares_after_transaction": "16425"
    },
    {
      "id": 160213,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2022-10-05",
      "transaction_shares": "1844",
      "transaction_price": "749.0",
      "transaction_type": "S",
      "shares_after_transaction": "16425"
    },
    {
      "id": 214401,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2022-10-05",
      "transaction_shares": "1844",
      "transaction_price": "749.0",
      "transaction_type": "S",
      "shares_after_transaction": "16425"
    },
    {
      "id": 20263,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-10-03",
      "transaction_shares": "2",
      "transaction_price": "705.39",
      "transaction_type": "S",
      "shares_after_transaction": "19580"
    },
    {
      "id": 20264,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-10-03",
      "transaction_shares": "600",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "20244"
    },
    {
      "id": 20276,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2022-10-03",
      "transaction_shares": "3346",
      "transaction_price": "724.0",
      "transaction_type": "S",
      "shares_after_transaction": "18269"
    },
    {
      "id": 20280,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2022-10-03",
      "transaction_shares": "279",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "279"
    },
    {
      "id": 40214,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-10-03",
      "transaction_shares": "2",
      "transaction_price": "705.39",
      "transaction_type": "S",
      "shares_after_transaction": "19580"
    },
    {
      "id": 40215,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-10-03",
      "transaction_shares": "600",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "20244"
    },
    {
      "id": 40253,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2022-10-03",
      "transaction_shares": "3346",
      "transaction_price": "724.0",
      "transaction_type": "S",
      "shares_after_transaction": "18269"
    },
    {
      "id": 40263,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2022-10-03",
      "transaction_shares": "279",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "279"
    },
    {
      "id": 72263,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-10-03",
      "transaction_shares": "2",
      "transaction_price": "705.39",
      "transaction_type": "S",
      "shares_after_transaction": "19580"
    },
    {
      "id": 72264,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-10-03",
      "transaction_shares": "600",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "20244"
    },
    {
      "id": 72315,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2022-10-03",
      "transaction_shares": "3346",
      "transaction_price": "724.0",
      "transaction_type": "S",
      "shares_after_transaction": "18269"
    },
    {
      "id": 72328,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2022-10-03",
      "transaction_shares": "279",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "279"
    },
    {
      "id": 113171,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-10-03",
      "transaction_shares": "2",
      "transaction_price": "705.39",
      "transaction_type": "S",
      "shares_after_transaction": "19580"
    },
    {
      "id": 113172,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-10-03",
      "transaction_shares": "600",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "20244"
    },
    {
      "id": 113228,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2022-10-03",
      "transaction_shares": "3346",
      "transaction_price": "724.0",
      "transaction_type": "S",
      "shares_after_transaction": "18269"
    },
    {
      "id": 113243,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2022-10-03",
      "transaction_shares": "279",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "279"
    },
    {
      "id": 160172,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-10-03",
      "transaction_shares": "2",
      "transaction_price": "705.39",
      "transaction_type": "S",
      "shares_after_transaction": "19580"
    },
    {
      "id": 160173,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-10-03",
      "transaction_shares": "600",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "20244"
    },
    {
      "id": 160238,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2022-10-03",
      "transaction_shares": "3346",
      "transaction_price": "724.0",
      "transaction_type": "S",
      "shares_after_transaction": "18269"
    },
    {
      "id": 160254,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2022-10-03",
      "transaction_shares": "279",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "279"
    },
    {
      "id": 214346,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-10-03",
      "transaction_shares": "2",
      "transaction_price": "705.39",
      "transaction_type": "S",
      "shares_after_transaction": "19580"
    },
    {
      "id": 214347,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-10-03",
      "transaction_shares": "600",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "20244"
    },
    {
      "id": 214436,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2022-10-03",
      "transaction_shares": "3346",
      "transaction_price": "724.0",
      "transaction_type": "S",
      "shares_after_transaction": "18269"
    },
    {
      "id": 214460,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2022-10-03",
      "transaction_shares": "279",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "279"
    }
  ]
}